Advertisement.
Advertisement.
Advertisement
Advertisement.
RAIN Rain Therapeutics Inc
975
| Market Cap | $54.67M |
| Volume | 3.71M |
| 52-Wk High | $11.32 |
| 52-Wk Low | $0.82 |
Pathos AI Completes Acquisition of Rain Oncology
Business Wire•6 months ago
Pathos AI, Inc. (Pathos) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (Merger Sub), successfully completed its tender offer to acquire all outstanding shares...
Share to Feed
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire•7 months ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL PR Newswire NEW YORK, Jan. 4, 2024 NEW...
PR Newswire•7 months ago
Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm PR Newswire NEW YORK, Jan. 3, 2024 NEW YORK...
PR Newswire•7 months ago
NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire•7 months ago